Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in β-cell gene expression and progression to diabetes

Diabetes. 2013 May;62(5):1557-68. doi: 10.2337/db12-0701. Epub 2012 Dec 28.

Abstract

The normal β-cell response to obesity-associated insulin resistance is hypersecretion of insulin. Type 2 diabetes develops in subjects with β-cells that are susceptible to failure. Here, we investigated the time-dependent gene expression changes in islets of diabetes-prone db/db and diabetes-resistant ob/ob mice. The expressions of adaptive unfolded protein response (UPR) genes were progressively induced in islets of ob/ob mice, whereas they declined in diabetic db/db mice. Genes important for β-cell function and maintenance of the islet phenotype were reduced with time in db/db mice, whereas they were preserved in ob/ob mice. Inflammation and antioxidant genes displayed time-dependent upregulation in db/db islets but were unchanged in ob/ob islets. Treatment of db/db mouse islets with the chemical chaperone 4-phenylbutyric acid partially restored the changes in several β-cell function genes and transcription factors but did not affect inflammation or antioxidant gene expression. These data suggest that the maintenance (or suppression) of the adaptive UPR is associated with β-cell compensation (or failure) in obese mice. Inflammation, oxidative stress, and a progressive loss of β-cell differentiation accompany diabetes progression. The ability to maintain the adaptive UPR in islets may protect against the gene expression changes that underlie diabetes development in obese mice.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / metabolism
  • Cytokines / genetics
  • Cytokines / metabolism
  • Diabetes Mellitus, Type 2 / etiology*
  • Diabetes Mellitus, Type 2 / immunology
  • Diabetes Mellitus, Type 2 / metabolism
  • Disease Progression
  • Disease Susceptibility
  • Down-Regulation / drug effects
  • Gene Expression Regulation* / drug effects
  • Insulin / metabolism
  • Insulin Secretion
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / immunology
  • Insulin-Secreting Cells / metabolism*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / immunology
  • Islets of Langerhans / metabolism*
  • Mice
  • Mice, Mutant Strains
  • Mice, Obese
  • Obesity / immunology
  • Obesity / metabolism
  • Obesity / physiopathology*
  • Oxidoreductases / genetics
  • Oxidoreductases / metabolism
  • Phenylbutyrates / pharmacology
  • RNA, Messenger / metabolism
  • Tissue Culture Techniques
  • Unfolded Protein Response* / drug effects
  • Up-Regulation / drug effects

Substances

  • Antioxidants
  • Apoptosis Regulatory Proteins
  • Cytokines
  • Insulin
  • Phenylbutyrates
  • RNA, Messenger
  • 4-phenylbutyric acid
  • Oxidoreductases